Value Forum
MNV
Market News Video
MNV MNV Model Portfolios
MNV
MNV
MNV
MNV
MNV
MNV
MNV
Free Dividend Report - Top Ranked Stocks

Featured MNV Articles:

Bullish Two Hundred Day Moving Average Cross - MDVN
Friday, April 5, 4:38 PM ET, by Market News Video Staff

In trading on Friday, shares of Medivation Inc (MDVN) crossed above their 200 day moving ...

Cepheid (CPHD) Shares Cross Below 200 DMA
Monday, April 8, 4:32 PM ET, by Market News Video Staff

In trading on Monday, shares of Cepheid (CPHD) crossed below their 200 day moving average ...

EXEL Crosses Above Key Moving Average Level
Thursday, April 11, 11:34 AM ET, by Market News Video Staff

In trading on Thursday, shares of Exelixis Inc (EXEL) crossed above their 200 day moving ...

Land INFI Even Cheaper Than Its Secondary?
Monday, April 15, 3:35 PM ET, by Market News Video Staff

Looking back to 4 days ago, Infinity Pharmaceuticals Inc (INFI) priced a 10,000,000 share secondary ...

Oversold Conditions For Dendreon Corp (DNDN)
Thursday, April 18, 4:29 PM ET, by Market News Video Staff

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy ...

  More articles:  1 2 3 4 5 6 7 next »

Exelixis Inc is Now Oversold (EXEL)

By Market News Video Staff, Wednesday, December 14, 12:31 PM ET
Now Playing: Learn About The RSI


If the video does not load after a few moments, Upgrade to the Latest Flash Player.

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100. A stock is considered to be oversold if the RSI reading falls below 30.

In trading on Wednesday, shares of Exelixis Inc (NASDAQ:EXEL) entered into oversold territory, hitting an RSI reading of 29.1, after changing hands as low as $4.09 per share. By comparison, the current RSI reading of the S&P 500 ETF (SPY) is 43.4. A bullish investor could look at EXEL's 29.1 RSI reading today as a sign that the recent heavy selling is in the process of exhausting itself, and begin to look for entry point opportunities on the buy side. The chart below shows the one year performance of EXEL shares:

Exelixis Inc 1 Year Performance Chart

Looking at the chart above, EXEL's low point in its 52 week range is $3.94 per share, with $12.82 as the 52 week high point — that compares with a last trade of $4.10. Find out what 9 other oversold stocks you need to know about »

According to the ETF Finder at ETF Channel, EXEL makes up 1.47% of the SPDR S&P Biotech ETF (AMEX:XBI) which is trading lower by about 1.3% on the day Wednesday.

     See what other ETFs contain EXEL »
     See what other stocks are held by XBI »

EXEL operates in the Biotechnology sector, among companies like Dynavax Technologies Corp (NASDAQ:DVAX) which is down about 2.2% today and has a current RSI reading of 47.9. Below is a three month price history chart comparing the stock performance of EXEL, versus DVAX.

EXEL,DVAX Relative Performance Chart


Free Trial: ''ETF CHANNEL FLEXIBLE GROWTH INVESTMENT PORTFOLIO''

The ETF Channel Flexible Growth Investment Portfolio is designed to seek growth for investors — anywhere and everywhere. The key to the program is our portfolio strategy allows us complete flexibility in terms of asset allocation as there are no predetermined guidelines as to the level of stocks, bonds, cash, regions, countries, sectors, commodities, or even asset classes in the portfolio! In short, this is a completely flexible portfolio designed to follow the performance trail wherever it leads us.

Find the right mix of model portfolios today at PortfolioChannel.com


Top Six Most Viewed Stories This Week @ Market News Video:
Analyst Moves:  RIG, APC, BSXAnalyst Moves: RIG, APC, BSX
Channel: Upgrades/Downgrades
Related symbols: RIG,APC,BSX,CS,JEF,WFC
Daily Wrap:  May 10, 2013Daily Wrap: May 10, 2013
Channel: Large Cap Stocks
Related symbols: MT,PCLN,GPS
Analyst Moves:  DISH, MDR, PCLNAnalyst Moves: DISH, MDR, PCLN
Channel: Upgrades/Downgrades
Related symbols: DISH,MDR,PCLN,WFC
Daily Wrap:  May 9, 2013Daily Wrap: May 9, 2013
Channel: Large Cap Stocks
Related symbols: DISH,ZUMZ,ROST
Hiring Picture Improves In AprilHiring Picture Improves In April
Channel: Economic News
Friday 5/10 Insider Buying Report: ROICFriday 5/10 Insider Buying Report: ROIC
Channel: Insider Buying Report
Related symbols: ROIC

This Article's Word Cloud:   AMEX   Channel   DVAX   Dynavax   ETFs   EXEL   Exelixis   Finder   Portfolio   Wednesday   about   after   asset   begin   below   cash   chart   current   designed   fearful   greedy   heavy   investor   level   look   lower   other   others   oversold   performance   point   portfolio   process   reading   share   shares   slideshow   stock   stocks   that   today   trading   versus   week   what   when   which   with   year   zero
MNV
MNV
About Us - Advertise - Contact Us - Embedding Videos - Licensing Videos - Partners - mRSS / RSS Feed - Terms of Use & Privacy Policy - Video Widget
MNV
Home  |  Analyst News  Dividend Report  Econonomic News  Insider Report  Large Caps  Market Movers  Week Ahead Report  Weekly Market Wrap
MNV
MNV MNV Stock Market Definitions
MNV

Exelixis Inc is Now Oversold (EXEL) | Market News Video | Copyright © 2008 - 2013, All Rights Reserved

Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners. In no way should any content contained herein be interpreted to represent trading or investment advice. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.